Denali Therapeutics (DNLI) EBIT Margin (2018 - 2026)
Denali Therapeutics (DNLI) reported EBIT Margin of -712.97% for Q3 2026, up 2909.15 percentage points from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) EBIT Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Denali Therapeutics' EBIT Margin came in at -2488.14%; for FY2023, it came in at -59.51%, up 254.65 percentage points from FY2022.
- EBIT Margin has a five-year change of -23.61 percentage points (FY2018 to FY2023).
- By year, EBIT Margin came in at -314.16% in FY2022 (+293.62 pp), -607.78% in FY2021 (-626.46 pp), 18.69% in FY2020 (+817.79 pp) and -799.10% in FY2019 (-763.20 pp).
- The Q3 2026 figure ranks as the highest quarterly EBIT Margin since Q2 2023.
- The high point for year-over-year EBIT Margin in five years was Q1 2022 (a gain of 741.10 percentage points); the low point was Q3 2023 (a drop of 5961.33 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Denali Therapeutics | 3.83 Bn | 743.92 Mn | 17.59 Mn | -712.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -712.97% |
| Jun 30, 2026 | -3,622.11% |
| Sep 30, 2023 | -8,981.45% |
| Jun 30, 2023 | 57.96% |
| Mar 31, 2023 | -343.80% |
| Dec 31, 2022 | -1,024.45% |
| Sep 30, 2022 | -3,020.12% |
| Jun 30, 2022 | -117.03% |
| Mar 31, 2022 | -157.80% |
| Dec 31, 2021 | -616.28% |
| Sep 30, 2021 | -1,619.55% |
| Jun 30, 2021 | -269.48% |
| Mar 31, 2021 | -898.90% |
| Dec 31, 2020 | 77.04% |
| Sep 30, 2020 | -640.01% |
| Jun 30, 2020 | -1,048.01% |
| Mar 31, 2020 | -1,663.90% |
| Dec 31, 2019 | -1,236.26% |
| Sep 30, 2019 | -368.68% |
| Jun 30, 2019 | -1,495.43% |
API Access
Denali Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();